marbofloxacin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
antibacterials, nalidixic acid derivatives 5572 115550-35-1

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • marbofloxacin
  • RO 09-1168
  • marbocyl
Fluoroquinolone carboxylic acid derivative
  • Molecular weight: 362.36
  • Formula: C17H19FN4O4
  • CLOGP: 0.66
  • LIPINSKI: 0
  • HAC: 8
  • HDO: 1
  • TPSA: 76.56
  • ALOGS: -2.14
  • ROTB: 2

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 -0.883 Moderate 0.66
caco2-efflux Caco-2 efflux ratio (BA/AB) 2.280 Moderate 0.66
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 7.447 10^-6 cm/s Moderate 0.66
dh-clint Dog hepatocyte intrinsic clearance 2.600 uL/min/10^6 cells Moderate 0.66
dppb Dog plasma protein binding (% unbound) 83.840 % Moderate 0.66
fcs-ppb Fetal calf serum protein binding (% unbound) 80.760 % Moderate 0.66
herg hERG pIC50 4.415 pIC50 Moderate 0.66
hh-clint Human hepatocyte intrinsic clearance 1.062 uL/min/10^6 cells Moderate 0.66
hlm-clint Human liver microsomal intrinsic clearance 3.006 uL/min/mg protein Moderate 0.66
hppb Human plasma protein binding (% unbound) 73.990 % Moderate 0.66
mdck-mdr1-bcrp-efflux MDCK-MDR1-BCRP efflux ratio 3.516 Moderate 0.66
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 8.570 Moderate 0.66
mh-clint Mouse hepatocyte intrinsic clearance 2.698 Moderate 0.66
mppb Mouse plasma protein binding (% unbound) 77.580 Moderate 0.66
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 9.462 Moderate 0.66
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 81.040 % Moderate 0.66
rat-kpuu-brain Rat brain Kpuu 0.098 % Moderate 0.66
rh-clint Rat hepatocyte intrinsic clearance 1.493 uL/min/10^6 cells Moderate 0.66
rh-fuinc Rat hepatocyte fraction unbound in incubation 90.100 % Moderate 0.66
rppb Rat plasma protein binding (% unbound) 53.390 % Moderate 0.66
solubility-dd Solubility at pH 7.4 in DMSO 879.023 uM Moderate 0.66

Approvals:

DateAgencyCompanyOrphan
None FDA

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
MeSH PA D000890 Anti-Infective Agents
MeSH PA D000900 Anti-Bacterial Agents
CHEBI has role CHEBI:36047 antibacterial drug

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

SpeciesUseRelation
Cats Bacterial infections Indication
Dogs Bacterial infections Indication

🐶 Veterinary products

ProductApplicantIngredients
Zeniquin Zoetis Inc. 1
Marboquin Dechra Veterinary Products LLC 1

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
CHEBI:132230 CHEBI
CHEMBL478120 ChEMBL_ID
C080260 MESH_SUPPLEMENTAL_RECORD_UI
13670 IUPHAR_LIGAND_ID
DB11426 DRUGBANK_ID
725614002 SNOMEDCT_US
C3654388 UMLSCUI
6807 INN_ID
D08156 KEGG_DRUG
60651 PUBCHEM_CID
017801 NDDF
8X09WU898T UNII
69256 RXNORM

Pharmaceutical products:

None